Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIA Multicenter 1 Week Treatment, Randomised, Double-Blind, Placebo Controlled Study of Depelestat in Patients Suffering From Acute Respiratory Distress Syndrome

NCT00455767 is registered in ClinicalTrials.gov with Debiopharm International SA as lead sponsor.

NCT NCT00455767
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00455767 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIA Multicenter 1 Week Treatment, Randomised, Double-Blind, Placebo Controlled Study of Depelestat in Patients Suffering From Acute Respiratory Distress Syndrome
Lead sponsor
Debiopharm International SA
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2006
Completion date
September 30, 2007
Enrollment
84 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, fibrosis, inflammation, lung disease, pulmonary fibrosis, respiratory disorders, respiratory distress syndrome, adult